CBER’s Laboratory Quality System Management Helps Keep Biological Product Standards High

By: Peter Marks, M.D., Ph.D. Part of the vision of the Center for Biologics Evaluation and Research (CBER) is to strengthen the Center as the preeminent regulatory organization for biologics. One way CBER is achieving this: Through the work of … Continue reading →
Source: FDA Voice - Category: American Health Source Type: blogs